Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults.
Creech CB; Dekker CL; Ho D; Phillips S; Mackey S; Murray-Krezan C; Grazia Pau M; Hendriks J; Brown V; Dally LG; Versteege I; Edwards KM; Human Vaccines & Immunotherapeutics, 2013, vol. 9, issue 12, p 2548, ISSN 2164554x. ISBN 2164554x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef